U.S. pays Pfizer, BioNTech $2 bln for vaccines

Published – July 22, 2020 6:36 pm
Pfizer and its German partner, BioNTech, secured a nearly $2 billion order from the U.S. government for 100 million doses of a COVID-19 vaccine that doesn’t yet exist.
Under the agreement, the U.S. can acquire up to 500 million additional doses.